Showing results (281-290 of 435) with videos related to
Sort By:
Pageof 44
Cancer|March 12, 2019
Clinical and molecular characterization of early-onset colorectal cancerAlexandra N Willauer, Yusha Liu, Allan A L Pereira, et al.European Journal of Cancer (Oxford, England : 1990)|August 31, 2024
BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancerMargherita Ambrosini, David Tougeron, Dominik Modest, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
An Exosome-Based Liquid Biopsy Predicts Depth of Response and Survival Outcomes to Cetuximab and Panitumumab in Metastatic Colorectal Cancer: The EXONERATE StudyCaiming Xu, Alessandro Mannucci, Francis Esposito, et al.Cancer Research Communications|April 16, 2026
BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study FindingsJames J Harding, Ralf Hofheinz, Elena Élez, et al.Gut|October 15, 2011
Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancerSang Cheul Oh, Yun-Yong Park, Eun Sung Park, et al.Journal of Gastrointestinal Oncology|January 13, 2017
Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution patternHumaid O Al-Shamsi, Jeremy Jones, Yazan Fahmawi, et al.BJC Reports|November 8, 2024
New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasisIsha Khanduri, Harufumi Maki, Anuj Verma, et al.The Lancet. Oncology|July 24, 2017
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 studyMichael J Overman, Ray McDermott, Joseph L Leach, et al.Nature Communications|October 21, 2017
Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancersChan-Young Ock, Jun-Eul Hwang, Bhumsuk Keam, et al.Journal of the National Cancer Institute|May 3, 2018
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal CancerJonathan M Loree, Ann M Bailey, Amber M Johnson, et al.Pageof 44